GlaxoSmithKline
GSK
#209
Rank
S$126.63 B
Marketcap
S$62.73
Share price
-0.33%
Change (1 day)
40.32%
Change (1 year)

GlaxoSmithKline (GSK) - Total assets

Total assets on the balance sheet as of September 2025 : S$106.86 Billion

According to GlaxoSmithKline's latest financial reports the company's total assets are S$106.86 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$101.42 B2.17%
2023-12-31S$99.28 B1.78%
2022-12-31S$97.54 B-32.42%
2021-12-31S$144.35 B-0.47%
2020-12-31S$145.03 B2.95%
2019-12-31S$140.88 B39.91%
2018-12-31S$100.69 B-1.2%
2017-12-31S$101.91 B-3.4%
2016-12-31S$105.50 B-5.82%
2015-12-31S$112.03 B33.97%
2014-12-31S$83.62 B-4.92%
2013-12-31S$87.95 B7.28%
2012-12-31S$81.98 B-0.85%
2011-12-31S$82.68 B-1.53%
2010-12-31S$83.97 B-13.76%
2009-12-31S$97.37 B17.93%
2008-12-31S$82.56 B-6.93%
2007-12-31S$88.71 B15.63%
2006-12-31S$76.72 B-1.73%
2005-12-31S$78.07 B10.11%
2004-12-31S$70.90 B-2.56%
2003-12-31S$72.77 B17.15%
2002-12-31S$62.11 B5.36%
2001-12-31S$58.95 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
S$148.32 B 38.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$270.49 B 153.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$167.87 B 57.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$139.03 B 30.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$197.39 B 84.72%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
S$51.64 B-51.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$1.22 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA